EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Overcoming Microenvironment-Driven Resistance to CAR-T Therapy in Multiple Myeloma

Gabriel Saez, Randy Khusial, Kamron Hamedi, Nathan Arreola, Helen Khuu, Heather Kissel

Lymphatics · 05.03.2026 · 4 (1) · 15

DOI: 10.3390/lymphatics4010015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lymphatics, online erschienen am 05.03.2026. Verfasst von Gabriel Saez und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

B cell maturation antigen (BCMA)-targeted chimeric antigen receptor T cell (CAR-T) therapy has transformed the treatment landscape for relapsed or refractory multiple myeloma (MM), with products such as idecabtagene vicleucel and ciltacabtagene autoleucel achieving high initial response rates, and in selected patient populations, durable treatment-free remission. However, a substantial proportion of patients still experience relapse, including antigen-positive progression, highlighting persistent limitations in long-term disease control across diverse clinical settings. An increasing body of evidence indicates that resistance to CAR-T therapy in MM is driven not only by tumor-intrinsic factors, but also by extrinsic pressures imposed by the bone marrow microenvironment (BMME). This review integrates current understanding of tumor-niche interactions that impair CAR-T persistence, trafficking, and effector function, including immunosuppressive cellular networks, inhibitory cytokine signaling, metabolic constraints, stromal adhesion, antigen modulation, and marrow remodeling. This review further examines emerging therapeutic strategies and next-generation CAR-T platforms.

Zitieren

APA

Saez, G., Khusial, R., Hamedi, K., Arreola, N., Khuu, H., & Kissel, H. (2026). Overcoming Microenvironment-Driven Resistance to CAR-T Therapy in Multiple Myeloma. Lymphatics, 4(1), 15. https://doi.org/10.3390/lymphatics4010015

Vancouver

Saez G, Khusial R, Hamedi K, Arreola N, Khuu H, Kissel H. Overcoming Microenvironment-Driven Resistance to CAR-T Therapy in Multiple Myeloma. Lymphatics. 2026;4(1):15. doi:10.3390/lymphatics4010015

BibTeX
@article{Saez2026,
  author = {Saez, Gabriel and Khusial, Randy and Hamedi, Kamron and Arreola, Nathan and Khuu, Helen and Kissel, Heather},
  title = {Overcoming Microenvironment-Driven Resistance to CAR-T Therapy in Multiple Myeloma},
  journal = {Lymphatics},
  year = {2026},
  volume = {4},
  number = {1},
  pages = {15},
  doi = {10.3390/lymphatics4010015}
}
Kostenlos starten →